Ticker LaunchIPO · BPTS
Biophytis SA
Biophytis SA (BPTS) priced its initial public offering on Feb 11, 2021 at $16.75 per ADS, raising $20.1M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $188.9M. H.C. Wainwright was lead-left underwriter. Reed Smith advised the company and Jones Day advised the underwriters.
Biophytis SA is a clinical-stage biotechnology company developing therapeutics that slow degenerative processes of aging and improve functional outcomes in age-related diseases such as sarcopenia and age-related macular degeneration, as well as severe respiratory failure in COVID-19 patients.
- Status
- IPO
- Ticker
- BPTS
- Exchange
- Nasdaq Capital Market
- Priced
- Feb 11, 2021
- IPO price
- $16.75 per ADS
- Raised
- $20.1M
- Market cap at IPO price
- $188.9M
- First filed
- May 22, 2019
- Underwriters
- H.C. Wainwright
- Company counsel
- Reed Smith
- Underwriters' counsel
- Jones Day
- Sector
- Biotech & pharma
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed May 22, 2019
- Latest amendment Feb 8, 2021
- Final prospectus (424B4) Feb 11, 2021
- All filings on EDGAR CIK 1768946
Other Biotech & pharma IPOs in 2021
- Decibel Therapeutics, Inc.DBTX · Feb 12, 2021 · $127.1M
- Longeveron Inc.LGVN · Feb 12, 2021 · $26.6M
- GRI Bio, Inc.VLON · Feb 11, 2021 · $18M
- Adagene Inc.ADAG · Feb 10, 2021
- Immunocore Holdings plcIMCR · Feb 8, 2021
- Lucira Health, Inc.LHDX · Feb 8, 2021 · $153M